학술논문

Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors

Document Type

Article

Author

Tolcher, A.W.; Kurzrock, R.; Valero, V.; Gonzalez, R.; Heist, R.S.; Tan, A.R.; Means-Powell, J.; Werner, T.L.; Becerra, C.; Wang, C.; Leonowens, C.; Kalyana-Sundaram, S.; Ellis, C.; Ibrahim, N.; Yan, L.; Kleha, J.F.; Gauvin, J.; D’Amelio, A.M.

Source

In: Cancer Chemotherapy and Pharmacology. (Cancer Chemotherapy and Pharmacology, 1 April 2020, 85(4):673-683)

Subject

Language

English

ISSN

14320843
03445704

Online Access

Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송